Review



visitect cd4 advanced disease lateral flow assay (visitect cd4 lfa)  (Omega Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Omega Diagnostics visitect cd4 advanced disease lateral flow assay (visitect cd4 lfa)
    Visitect Cd4 Advanced Disease Lateral Flow Assay (Visitect Cd4 Lfa), supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/visitect+cd4+advanced+disease+lateral+flow+assay+(visitect+cd4+lfa)/visitect+cd4++advanced+disease+lateral+flow+assay/10__1016_slash_j__cegh__2024__101616-40-1-12
    Average 90 stars, based on 1 article reviews
    visitect cd4 advanced disease lateral flow assay (visitect cd4 lfa) - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Lateral Flow Assay:

    Article Title: Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol
    Article Snippet: .. The novel Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Omega Diagnostics, Scotland, UK; VISITECT CD4 LFA), is the first disposable point-of-care test, which allows visual interpretation of a result of above or below 200 CD4 cells/μL. ..

    Article Title: Diagnostic performance and usability of the VISITECT CD4 semi-quantitative test for advanced HIV disease screening
    Article Snippet: .. Developed by the Burnet Institute, the Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (Visitect CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable POC test that offers an estimation of the CD4 protein on the surface of CD4+ T cells, providing a semi-quantitative results at a threshold of 200cells/mm 3 [ ]. ..

    Article Title: Accuracy, use and acceptability of the VISITECT CD4 semi-quantitative test to advance HIV disease screening in routine programmatic settings in Tanzania
    Article Snippet: .. The Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (VISITECT CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable, point-of-care, instrument-free, immunochromatographic assay that uses a monoclonal antibody specific for an extracellular region on the surface of CD4+ T cells in human whole blood to provide a visual semiquantitative result indicating whether the CD4 cell count is above or below 200 cells/μl.5 As an instrument-free device, WHO validated and prequalified, VISITECT CD4 does not require preventive maintenance, and can be used by non-laboratory personnel, providing results within 45 min.6 In a multi-site accuracy study done in Malawi, Democratic Republic of Congo and Zimbabwe in adults age >18 years, the sensitivity and specificity of VISITECT CD4 using finger-prick capillary blood was 98.3 % (95 % confidence interval (CI); 95.0%–99.6 %) and 77.2 % (95 % CI; 71.6%–82.2 %)6 respectively. ..

    Immunochromatographic Assay:

    Article Title: Accuracy, use and acceptability of the VISITECT CD4 semi-quantitative test to advance HIV disease screening in routine programmatic settings in Tanzania
    Article Snippet: .. The Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (VISITECT CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable, point-of-care, instrument-free, immunochromatographic assay that uses a monoclonal antibody specific for an extracellular region on the surface of CD4+ T cells in human whole blood to provide a visual semiquantitative result indicating whether the CD4 cell count is above or below 200 cells/μl.5 As an instrument-free device, WHO validated and prequalified, VISITECT CD4 does not require preventive maintenance, and can be used by non-laboratory personnel, providing results within 45 min.6 In a multi-site accuracy study done in Malawi, Democratic Republic of Congo and Zimbabwe in adults age >18 years, the sensitivity and specificity of VISITECT CD4 using finger-prick capillary blood was 98.3 % (95 % confidence interval (CI); 95.0%–99.6 %) and 77.2 % (95 % CI; 71.6%–82.2 %)6 respectively. ..

    Cell Counting:

    Article Title: Accuracy, use and acceptability of the VISITECT CD4 semi-quantitative test to advance HIV disease screening in routine programmatic settings in Tanzania
    Article Snippet: .. The Omega VISITECT CD4 Advanced Disease Lateral Flow Assay (VISITECT CD4 LFA) (Omega Diagnostics, Scotland, UK), is a disposable, point-of-care, instrument-free, immunochromatographic assay that uses a monoclonal antibody specific for an extracellular region on the surface of CD4+ T cells in human whole blood to provide a visual semiquantitative result indicating whether the CD4 cell count is above or below 200 cells/μl.5 As an instrument-free device, WHO validated and prequalified, VISITECT CD4 does not require preventive maintenance, and can be used by non-laboratory personnel, providing results within 45 min.6 In a multi-site accuracy study done in Malawi, Democratic Republic of Congo and Zimbabwe in adults age >18 years, the sensitivity and specificity of VISITECT CD4 using finger-prick capillary blood was 98.3 % (95 % confidence interval (CI); 95.0%–99.6 %) and 77.2 % (95 % CI; 71.6%–82.2 %)6 respectively. ..



    Similar Products

    90
    Omega Diagnostics visitect cd4 advanced disease lateral flow assay (visitect cd4 lfa)
    Visitect Cd4 Advanced Disease Lateral Flow Assay (Visitect Cd4 Lfa), supplied by Omega Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/visitect+cd4+advanced+disease+lateral+flow+assay+(visitect+cd4+lfa)/visitect+cd4++advanced+disease+lateral+flow+assay/10__1016_slash_j__cegh__2024__101616-40-1-12
    Average 90 stars, based on 1 article reviews
    visitect cd4 advanced disease lateral flow assay (visitect cd4 lfa) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results